Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy for management of cryptogenic stroke

Main Editor Ton Kuijpers, Fred Spencer, Reed Siemieniuk, Gordon Guyatt
Language en
Last Update Jul 26, 2018
Published Date Jul 26, 2018
Contact
Disclaimer

Sponsors This guideline was not funded.
Abstract

A BMJ-Rapid Recommendation on patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy for management of cryptogenic stroke. This is the 10th BMJ-RapidRec, initiated in response to three recently published large trials in the New England Journal of Medicine (Mas 2017;377(11):1011-1021; Saver 2017;377(11):1022-1032; S√łndergaard 2017;377:1033-42). Roles: Panel Chair: Fred Spencer Methods Editors: Ton Kuijpers Oversight from RapidRecs executive: Reed Siemieniuk, Thomas Agoritsas, Gordon Guyatt, Per Olav Vandvik Systematic Review Lead: Hassan Mir

PICOS
PICO 2.1
P: Patients with cryptogenic stroke ,
I: PFO closure plus antiplatelet therapy ,
C: Antiplatelet therapy ,
O: ,

PICO 2.2
P: Patients with cryptogenic stroke
I: PFO closure plus antiplatelet therapy
C: Anticoagulation
O:

PICO 2.3
P: Patients with cryptogenic stroke
I: Anticoagulation
C: Antiplatelet
O: